What drugs does ISTX make?

ISTX has 1 FDA-approved drugs including ZEVTERA.

What therapeutic areas does ISTX focus on?

ISTX focuses primarily on Infectious Disease and Dermatology.

← Back

Data updated: Mar 10, 2026

ISTX

Infectious DiseaseDermatology

Pharma

ISTX is a pharmaceutical company focused on Infectious Disease, Dermatology. Key products include ZEVTERA.

2024

Since

Drugs

Trials

Approved (2yr)

Key Drugs

ZEVTERA

ceftobiprole medocaril sodium

5 indications · 2024

Recent Activity

ZEVTERA 2024-04-03

Type 1 - New Molecular Entity

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%

1 drugs

Dermatology 50%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Pfizer big-pharma

Infectious Disease, Dermatology

Baxter specialty

Infectious Disease, Dermatology

B BRAUN specialty

Infectious Disease, Dermatology

COSETTE other

Dermatology, Infectious Disease

BAUSCH AND LOMB specialty

Infectious Disease, Dermatology

ISTX

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (1)

Active (1)

Discontinued (0)

Company Info